Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Vaccine|December 1, 1989
Immunogenicity of a new type of yeast-derived hepatitis B vaccine consisting of M (pre-S2 + S) protein particlesM Hazama, M Takaoki, K Ohfune, et al.
Biochemical and Biophysical Research Communications|August 15, 1985
Production of cytotoxic factor(s) in human T cell lines transformed by a human retrovirusS Hinuma, K Naruo, K Tsukamoto, et al.
British Journal of Cancer|June 1, 1985
Production of plasminogen activators by human T-cell leukaemia virus-transformed human T cell linesS Hinuma, S Honda, K Tsukamoto, et al.
Immunology|April 1, 1993
Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2M Hazama, A Mayumi-Aono, T Miyazaki, et al.
The Journal of Infectious Diseases|April 1, 1994
Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion proteinM Nakao, M Hazama, A Mayumi-Aono, et al.
Immunology|February 1, 1987
Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cellsS Hinuma, K Naruo, K Ootsu, et al.
Brain Research. Developmental Brain Research|June 20, 2001
Developmental expression of prolactin releasing peptide in the rat brain: localization of messenger ribonucleic acid and immunoreactive neuronsT Yano, N Iijima, Y Kataoka, et al.
Biochimica Et Biophysica Acta|October 18, 1994
Molecular cloning and functional expression of a human thyrotropin-releasing hormone (TRH) receptor geneS Hinuma, M Hosoya, K Ogi, et al.
Clinical and Experimental Immunology|May 1, 1989
Detection and characterization of anti-tumour effector cells in Meth-A-bearing mice treated with recombinant human interleukin 2K I Naruo, S Hinuma, O Shiho, et al.
Vaccine|January 1, 1993
Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2M Hazama, A Mayumi-Aono, N Asakawa, et al.
Pageof 5